Amlexanox for Type 2 Diabetes and Obesity

Amlexanox for Type 2 Diabetes and Obesity

Conditions: Diabetes Mellitus Type 2; Non Alcoholic Fatty Liver Disease; Obesity
Interventions: Drug: Amlexanox
Sponsors: University of Michigan
Terminated

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

January 18, 2024Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Comments